Global Human Antihistamine Drug Market Based on Product Types: (H-1 Receptor Antagonists, H-2 Receptor Antagonists) Based on Applications: (Allergic Rhinitis/Hay Fever, Allergic Conjunctivitis, Hives and Other Skin Rashes, Colds, Food Allergies, Other Applications) by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Human Antihistamines Drug Market Overview:

The global Human Antihistamines Drug market is projected to reach a valuation of USD 623.92 Mn by 2032 at a CAGR of 9.30%, from USD 256.41 Mn in 2022.

Antihistamines are medications that can help with symptoms of allergies, gastrointestinal issues, colds, anxiety, and other ailments. These drugs are even intended to treat issues caused by an overabundance of histamine, a chemical produced by the immune system.

Antihistamines are classified into two groups: H-1 receptor antagonists or H-1 blockers are the first subtypes. Antihistamines of this type are used to treat allergy symptoms. H-2 receptor antagonists or H-2 blockers are the second subtypes. They’re used to treat gastrointestinal issues like GERD (also known as acid reflux), gastritis, peptic ulcers, motion sickness, nausea, and vomiting, among other disorders.
The H-1 blocker subtype is further divided into two groups — first-generation antihistamines and second-generation antihistamines.

Detailed Segmentation:

The global human antihistamine drug market is segmented on the basis of – Product Types, Applications, and regions. Represented below is a detailed segmental description:

Based on Product Types:

• H-1 Receptor Antagonists
• H-2 Receptor Antagonists

Based on Applications:

• Allergic Rhinitis/Hay Fever
• Allergic Conjunctivitis
• Hives and Other Skin Rashes
• Colds
• Food Allergies
• Heartburn
• Gastroesophageal Reflux Disease (GERD)
• COVID
• Other Applications

Based on Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Market Dynamics:

Drivers for the Global Human Antihistamine Drug Market:

The increasing usage of Artificial Intelligence (AI) applications in the healthcare industry are expected to propel this market ahead. AI can help practitioners with a range of activities, including patient and symptom evaluations, by assisting them and providing decision support. AI is also being used to accelerate the creation of new medications, predict disease outbreaks, and enhance overall healthcare outcomes, all these factors are expected to boost this market forward over the forecast period.

Restraints for the Global Human Antihistamine Drug Market:

This market’s expansion is expected to be hampered by expensive maintenance costs. Additionally, security concerns and interoperability issues are expected to impede the global healthcare human antihistamine drug market’s revenue growth.

Opportunity for the Global Human Antihistamine Drug Market:

The utilization of big data and cloud computing services is expected to increase multifold in the coming years, resulting in further market expansion prospects. Furthermore, because of the high investments being made in the healthcare sector, the global healthcare IT industry is expected to reflect exponential economic growth, in turn, complementing this industry in the process.

Key players in this market are:

• Merck & Co. Inc.
• Prestige Consumer Healthcare Inc.
• Johnson & Johnson
• The Procter & Gamble Company
• Pfizer Inc.
• Amarin Corporation
• Meda Pharmaceuticals Inc.
• Bayer AG
• Sanofi S.A.
• GlaxoSmithKline
• Xi’an Janssen Pharmaceutical Co. Ltd.
• Nanjing Haichen Pharmaceutical Co. Ltd.
• Yangtze River Pharmaceutical Group
• Others

For the Human Antihistamines Drug Market research study, the following years have been considered to estimate the market size: